Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
Prospective, longitudinal, multinational, observational study that will collect data on how
 patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community
 practices.
The COMPLETE registry is a prospective, longitudinal, multinational, observational study that
 will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in
 academic and community practices. The registry will enroll newly-diagnosed patients with PTCL
 treated with a variety of regimens. The COMPLETE registry is designed to better understand
 PTCL patient characteristics, treatments, and outcomes to help design and understand future
 clinical trials.
Inclusion Criteria:

 -  Patient is newly diagnosed with Peripheral T-cell Lymphoma (PTCL):

 -  Aggressive natural killer (NK)-cell leukemia

 -  Adult T-cell lymphoma/leukemia (human T-cell leukemia virus [HTLV] 1+)

 -  Angioimmunoblastic T-cell lymphoma

 -  Anaplastic large cell lymphoma (ALCL), primary systemic type (ALK+, ALK-)

 -  PTCL, not otherwise specified (NOS)

 -  T/NK-cell lymphoma, nasal type

 -  Enteropathy-type intestinal lymphoma

 -  Hepatosplenic T-cell lymphoma

 -  Subcutaneous panniculitis T-cell lymphoma

 -  Transformed mycosis fungoides (at diagnosis of transformation)

 -  T-cell prolymphocytic leukemia (T-PLL)

 -  Cutaneous gamma/delta (γ/δ) T-cell lymphoma

 -  Cutaneous aggressive CD8+ T-cell lymphoma

 -  Hematodermic neoplasms (blastic plasmacytoid dendritic cell neoplasm)

 -  Systemic Epstein Barr Virus (EBV)+ T-cell lymphomas (T-cell lymphoproliferative
 disorders of childhood)

 -  Other T-Cell lymphomas that are not listed in the Exclusion Criteria

 -  Patient gives written informed consent

 Exclusion Criteria:

 -  Patient has other T- or NK-cell malignancies including:

 -  Precursor T/NK neoplasms

 -  T-cell large granular lymphocytic leukemia

 -  Mycosis fungoides, other than transformed mycosis fungoides

 -  Sézary syndrome

 -  Primary cutaneous CD30+ disorders: ALCL and lymphomatoid papulosis